|
|||||
|
|
TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate |
|
| Authors: | Danila Daniel C Anand Aseem Sung Clifford C Heller Glenn Leversha Margaret A Cao Long Lilja Hans Molina Arturo Sawyers Charles L Fleisher Martin Scher Howard I |
| Institution: | a Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA b Department of Medicine, Weill Cornell Medical College, New York, NY, USA c Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA d Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA e Molecular Cytogenetic Core Laboratory, Memorial Sloan-Kettering Cancer Center, New York, NY, USA f Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA g Ortho Biotech Oncology Research and Development, a unit of Cougar Biotechnology, Los Angeles, CA, USA h Program in Human Oncology and Pathogenesis (HOPP), Memorial Sloan-Kettering Cancer Center, New York, NY, USA |
| Abstract: | |
| Keywords: | Abiraterone Biomarker Circulating tumor cells Prostate cancer Prostate-specific antigen TMPRSS2-ERG fusion |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |